Abstract
The current case describes epistaxis in a patient treated with a daily regimen of topiramate 100mg for migraine. The patient had not a past medical history of nosebleeds and laboratory parameters were within normal ranges. She was then advised to withdraw topiramate, and the epistaxis resolved within 12 hours after its discontinuation. Since then, the patient never complained other blood clotting disorders. The potential antiplatelet activity of topiramate is discussed.
Keywords: Topiramate, epistaxis, calcium-channel blockers, blood clotting
Current Drug Safety
Title: A Case of Topiramate-Induced Epistaxis
Volume: 4 Issue: 3
Author(s): Giovanni Polimeni, Rosario Grugno, Antongiulio Vitetta, Francesco Cordici, Antonella Alagna, Achille P. Caputi and Placido Bramanti
Affiliation:
Keywords: Topiramate, epistaxis, calcium-channel blockers, blood clotting
Abstract: The current case describes epistaxis in a patient treated with a daily regimen of topiramate 100mg for migraine. The patient had not a past medical history of nosebleeds and laboratory parameters were within normal ranges. She was then advised to withdraw topiramate, and the epistaxis resolved within 12 hours after its discontinuation. Since then, the patient never complained other blood clotting disorders. The potential antiplatelet activity of topiramate is discussed.
Export Options
About this article
Cite this article as:
Polimeni Giovanni, Grugno Rosario, Vitetta Antongiulio, Cordici Francesco, Alagna Antonella, Caputi P. Achille and Bramanti Placido, A Case of Topiramate-Induced Epistaxis, Current Drug Safety 2009; 4 (3) . https://dx.doi.org/10.2174/157488609789007001
DOI https://dx.doi.org/10.2174/157488609789007001 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rationale Design, Synthesis, and Pharmacological Evaluation of Isatin Analogues as Antiseizure Agents
Letters in Drug Design & Discovery Advanced Intraoperative MR Imaging
Current Medical Imaging Tuning and Fine-Tuning of Synapses with Adenosine
Current Neuropharmacology Drug Repositioning: A Unique Approach to Refurbish Drug Discovery
Current Drug Discovery Technologies An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors
Central Nervous System Agents in Medicinal Chemistry Dynorphin Convertases and their Functions in CNS
Current Pharmaceutical Design SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain
Current Molecular Pharmacology Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities
Current Neuropharmacology Kynurenines in the Central Nervous System: Recent Developments
Central Nervous System Agents in Medicinal Chemistry Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Current Neuropharmacology Choline Nutrition Programs Brain Development Via DNA and Histone Methylation
Central Nervous System Agents in Medicinal Chemistry Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Dietary and Plant Polyphenols Exert Neuroprotective Effects and Improve Cognitive Function in Cerebral Ischemia
Recent Patents on Food, Nutrition & Agriculture Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets Automated Electrophysiology in Drug Discovery
Current Pharmaceutical Design Synthesis of Novel 1-benzhydryl-4-(3-(piperidin-4-yl)propyl) Piperidine Sulfonamides as Anticonvulsant Agents
Letters in Drug Design & Discovery HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design PDZ Domain Protein-Protein Interactions: A Case Study with PICK1
Current Topics in Medicinal Chemistry MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design